Diaceutics PLC Announces Notice of AGM and Posting of Annual Report
The healthcare technology company announces the details of its upcoming annual general meeting and the availability of its annual report.
The healthcare technology company announces the details of its upcoming annual general meeting and the availability of its annual report.
The chair of Diaceutics PLC's spouse has sold a portion of their shareholding in the company.
The diagnostic commercialisation company reported strong revenue growth and improved margins, with expectations to return to profitability in 2025, despite ongoing economic uncertainties.
The healthcare technology company announces changes to PDMR shareholdings and the implementation of a share incentive plan for employees.
The healthcare technology company announces plans to release its annual results and hold investor presentations.
The healthcare technology company announces changes to its PDMR shareholdings and share incentive plan.
The diagnostic commercialization company secures a lucrative contract extension with a major pharmaceutical partner, potentially worth up to £18.5 million in recurring service revenues over the next several years.
The diagnostic company has announced a change in its shareholder base, with Danske Bank A/S increasing its stake to 3.99% of the voting rights.
The diagnostic commercialisation company announces PDMR share purchases under its employee incentive plan.
The healthcare technology company announces a non-executive director has purchased a small number of shares, a routine regulatory disclosure.